Galenica Ag Stock Performance
| GALNF Stock | USD 116.19 11.19 10.66% |
On a scale of 0 to 100, Galenica holds a performance score of 12. The company retains a Market Volatility (i.e., Beta) of -0.21, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Galenica are expected to decrease at a much lower rate. During the bear market, Galenica is likely to outperform the market. Please check Galenica's total risk alpha, as well as the relationship between the rate of daily change and period momentum indicator , to make a quick decision on whether Galenica's current trending patterns will revert.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Galenica AG are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Galenica reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 59.8 M | |
| Total Cashflows From Investing Activities | -88.2 M |
Galenica |
Galenica Relative Risk vs. Return Landscape
If you would invest 7,525 in Galenica AG on September 27, 2025 and sell it today you would earn a total of 4,094 from holding Galenica AG or generate 54.41% return on investment over 90 days. Galenica AG is currently producing 0.7967% returns and takes up 5.1378% volatility of returns over 90 trading days. Put another way, 46% of traded pink sheets are less volatile than Galenica, and 84% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Galenica Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Galenica's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Galenica AG, and traders can use it to determine the average amount a Galenica's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1551
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | GALNF | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average Galenica is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Galenica by adding it to a well-diversified portfolio.
Galenica Fundamentals Growth
Galenica Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Galenica, and Galenica fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Galenica Pink Sheet performance.
| Return On Equity | 0.15 | |||
| Return On Asset | 0.0492 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.05 % | |||
| Current Valuation | 4.38 B | |||
| Shares Outstanding | 49.64 M | |||
| Price To Earning | 22.17 X | |||
| Price To Book | 3.03 X | |||
| Price To Sales | 0.98 X | |||
| Revenue | 3.83 B | |||
| EBITDA | 306.48 M | |||
| Cash And Equivalents | 20.97 M | |||
| Cash Per Share | 0.42 X | |||
| Total Debt | 380.31 M | |||
| Debt To Equity | 0.57 % | |||
| Book Value Per Share | 23.35 X | |||
| Cash Flow From Operations | 333.1 M | |||
| Earnings Per Share | 3.74 X | |||
| Total Asset | 2.57 B | |||
About Galenica Performance
By analyzing Galenica's fundamental ratios, stakeholders can gain valuable insights into Galenica's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Galenica has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Galenica has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Galenica AG operates as a healthcare service provider in Switzerland and internationally. The company was founded in 1927 and is headquartered in Bern, Switzerland. Galenica operates under Medical Distribution classification in the United States and is traded on OTC Exchange. It employs 5517 people.Things to note about Galenica AG performance evaluation
Checking the ongoing alerts about Galenica for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Galenica AG help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Galenica AG is way too risky over 90 days horizon | |
| Galenica AG appears to be risky and price may revert if volatility continues |
- Analyzing Galenica's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Galenica's stock is overvalued or undervalued compared to its peers.
- Examining Galenica's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Galenica's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Galenica's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Galenica's pink sheet. These opinions can provide insight into Galenica's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Galenica Pink Sheet analysis
When running Galenica's price analysis, check to measure Galenica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Galenica is operating at the current time. Most of Galenica's value examination focuses on studying past and present price action to predict the probability of Galenica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Galenica's price. Additionally, you may evaluate how the addition of Galenica to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |